Utah Medical Products (UTMD) Competitors

$63.70 -0.35 (-0.55%)

Closing price 05/14/2026 04:00 PM Eastern

Extended Trading

$63.70 0.00 (0.00%)

As of 04:08 AM Eastern

UTMD vs. QDEL, CERS, OSUR, ANIK, and WST

Should you buy Utah Medical Products stock or one of its competitors? MarketBeat compares Utah Medical Products with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Utah Medical Products include QuidelOrtho (QDEL), Cerus (CERS), OraSure Technologies (OSUR), Anika Therapeutics (ANIK), and West Pharmaceutical Services (WST). These companies are all part of the "health care supplies" industry.

How does Utah Medical Products compare to QuidelOrtho?

Utah Medical Products (NASDAQ:UTMD) and QuidelOrtho (NASDAQ:QDEL) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, dividends, analyst recommendations, profitability, earnings, valuation and risk.

Utah Medical Products has a net margin of 28.90% compared to QuidelOrtho's net margin of -45.57%. Utah Medical Products' return on equity of 9.13% beat QuidelOrtho's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Utah Medical Products	28.90%	9.13%	8.86%
QuidelOrtho	-45.57%	4.25%	1.56%

QuidelOrtho has a consensus target price of $14.88, indicating a potential upside of 30.60%. Given QuidelOrtho's higher possible upside, analysts clearly believe QuidelOrtho is more favorable than Utah Medical Products.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Utah Medical Products	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
QuidelOrtho	3 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

In the previous week, QuidelOrtho had 5 more articles in the media than Utah Medical Products. MarketBeat recorded 8 mentions for QuidelOrtho and 3 mentions for Utah Medical Products. QuidelOrtho's average media sentiment score of 0.57 beat Utah Medical Products' score of 0.42 indicating that QuidelOrtho is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Utah Medical Products	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
QuidelOrtho	2 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Utah Medical Products has a beta of 0.37, indicating that its share price is 63% less volatile than the broader market. Comparatively, QuidelOrtho has a beta of 0.75, indicating that its share price is 25% less volatile than the broader market.

69.6% of Utah Medical Products shares are owned by institutional investors. Comparatively, 99.0% of QuidelOrtho shares are owned by institutional investors. 8.0% of Utah Medical Products shares are owned by company insiders. Comparatively, 0.8% of QuidelOrtho shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Utah Medical Products has higher earnings, but lower revenue than QuidelOrtho. QuidelOrtho is trading at a lower price-to-earnings ratio than Utah Medical Products, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Utah Medical Products	$38.52M	5.26	$11.29M	$3.38	18.85
QuidelOrtho	$2.73B	0.28	-$1.13B	-$17.82	N/A

Summary

Utah Medical Products beats QuidelOrtho on 9 of the 15 factors compared between the two stocks.

How does Utah Medical Products compare to Cerus?

Cerus (NASDAQ:CERS) and Utah Medical Products (NASDAQ:UTMD) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, analyst recommendations, media sentiment, dividends, risk, earnings, valuation and institutional ownership.

Utah Medical Products has lower revenue, but higher earnings than Cerus. Cerus is trading at a lower price-to-earnings ratio than Utah Medical Products, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cerus	$206.13M	2.44	-$15.63M	-$0.05	N/A
Utah Medical Products	$38.52M	5.26	$11.29M	$3.38	18.85

78.4% of Cerus shares are held by institutional investors. Comparatively, 69.6% of Utah Medical Products shares are held by institutional investors. 5.6% of Cerus shares are held by insiders. Comparatively, 8.0% of Utah Medical Products shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Cerus has a beta of 1.62, suggesting that its stock price is 62% more volatile than the broader market. Comparatively, Utah Medical Products has a beta of 0.37, suggesting that its stock price is 63% less volatile than the broader market.

Utah Medical Products has a net margin of 28.90% compared to Cerus' net margin of -4.41%. Utah Medical Products' return on equity of 9.13% beat Cerus' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cerus	-4.41%	-15.18%	-4.38%
Utah Medical Products	28.90%	9.13%	8.86%

In the previous week, Cerus and Cerus both had 3 articles in the media. Cerus' average media sentiment score of 1.50 beat Utah Medical Products' score of 0.42 indicating that Cerus is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cerus	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Utah Medical Products	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Cerus presently has a consensus target price of $4.00, suggesting a potential upside of 59.36%. Given Cerus' stronger consensus rating and higher possible upside, research analysts plainly believe Cerus is more favorable than Utah Medical Products.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cerus	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Utah Medical Products	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Utah Medical Products beats Cerus on 8 of the 15 factors compared between the two stocks.

How does Utah Medical Products compare to OraSure Technologies?

Utah Medical Products (NASDAQ:UTMD) and OraSure Technologies (NASDAQ:OSUR) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, valuation, analyst recommendations, risk, media sentiment, earnings, dividends and institutional ownership.

Utah Medical Products has a net margin of 28.90% compared to OraSure Technologies' net margin of -66.42%. Utah Medical Products' return on equity of 9.13% beat OraSure Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Utah Medical Products	28.90%	9.13%	8.86%
OraSure Technologies	-66.42%	-18.57%	-15.71%

69.6% of Utah Medical Products shares are held by institutional investors. Comparatively, 93.5% of OraSure Technologies shares are held by institutional investors. 8.0% of Utah Medical Products shares are held by company insiders. Comparatively, 3.9% of OraSure Technologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Utah Medical Products has a beta of 0.37, suggesting that its share price is 63% less volatile than the broader market. Comparatively, OraSure Technologies has a beta of 0.89, suggesting that its share price is 11% less volatile than the broader market.

Utah Medical Products has higher earnings, but lower revenue than OraSure Technologies. OraSure Technologies is trading at a lower price-to-earnings ratio than Utah Medical Products, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Utah Medical Products	$38.52M	5.26	$11.29M	$3.38	18.85
OraSure Technologies	$115.02M	1.77	-$68.73M	-$1.04	N/A

OraSure Technologies has a consensus target price of $3.00, suggesting a potential upside of 1.69%. Given OraSure Technologies' higher probable upside, analysts plainly believe OraSure Technologies is more favorable than Utah Medical Products.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Utah Medical Products	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
OraSure Technologies	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67

In the previous week, OraSure Technologies had 3 more articles in the media than Utah Medical Products. MarketBeat recorded 6 mentions for OraSure Technologies and 3 mentions for Utah Medical Products. OraSure Technologies' average media sentiment score of 1.18 beat Utah Medical Products' score of 0.42 indicating that OraSure Technologies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Utah Medical Products	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
OraSure Technologies	0 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Utah Medical Products beats OraSure Technologies on 9 of the 15 factors compared between the two stocks.

How does Utah Medical Products compare to Anika Therapeutics?

Utah Medical Products (NASDAQ:UTMD) and Anika Therapeutics (NASDAQ:ANIK) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, analyst recommendations, media sentiment, earnings, valuation, institutional ownership, dividends and profitability.

Utah Medical Products has a net margin of 28.90% compared to Anika Therapeutics' net margin of -9.52%. Utah Medical Products' return on equity of 9.13% beat Anika Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Utah Medical Products	28.90%	9.13%	8.86%
Anika Therapeutics	-9.52%	-5.90%	-4.52%

69.6% of Utah Medical Products shares are held by institutional investors. Comparatively, 91.5% of Anika Therapeutics shares are held by institutional investors. 8.0% of Utah Medical Products shares are held by company insiders. Comparatively, 12.1% of Anika Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Utah Medical Products has a beta of 0.37, meaning that its stock price is 63% less volatile than the broader market. Comparatively, Anika Therapeutics has a beta of 0.16, meaning that its stock price is 84% less volatile than the broader market.

Utah Medical Products has higher earnings, but lower revenue than Anika Therapeutics. Anika Therapeutics is trading at a lower price-to-earnings ratio than Utah Medical Products, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Utah Medical Products	$38.52M	5.26	$11.29M	$3.38	18.85
Anika Therapeutics	$112.82M	1.81	-$10.88M	-$0.79	N/A

Anika Therapeutics has a consensus target price of $17.00, suggesting a potential upside of 10.82%. Given Anika Therapeutics' higher possible upside, analysts clearly believe Anika Therapeutics is more favorable than Utah Medical Products.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Utah Medical Products	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Anika Therapeutics	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Utah Medical Products had 2 more articles in the media than Anika Therapeutics. MarketBeat recorded 3 mentions for Utah Medical Products and 1 mentions for Anika Therapeutics. Anika Therapeutics' average media sentiment score of 1.87 beat Utah Medical Products' score of 0.42 indicating that Anika Therapeutics is being referred to more favorably in the news media.

Company	Overall Sentiment
Utah Medical Products	Neutral
Anika Therapeutics	Very Positive

Summary

Utah Medical Products beats Anika Therapeutics on 9 of the 15 factors compared between the two stocks.

How does Utah Medical Products compare to West Pharmaceutical Services?

Utah Medical Products (NASDAQ:UTMD) and West Pharmaceutical Services (NYSE:WST) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, dividends, valuation, analyst recommendations, media sentiment, earnings, profitability and institutional ownership.

Utah Medical Products has a net margin of 28.90% compared to West Pharmaceutical Services' net margin of 16.85%. West Pharmaceutical Services' return on equity of 19.03% beat Utah Medical Products' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Utah Medical Products	28.90%	9.13%	8.86%
West Pharmaceutical Services	16.85%	19.03%	14.06%

West Pharmaceutical Services has higher revenue and earnings than Utah Medical Products. Utah Medical Products is trading at a lower price-to-earnings ratio than West Pharmaceutical Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Utah Medical Products	$38.52M	5.26	$11.29M	$3.38	18.85
West Pharmaceutical Services	$3.22B	6.58	$493.70M	$7.48	40.12

Utah Medical Products pays an annual dividend of $1.24 per share and has a dividend yield of 1.9%. West Pharmaceutical Services pays an annual dividend of $0.88 per share and has a dividend yield of 0.3%. Utah Medical Products pays out 36.7% of its earnings in the form of a dividend. West Pharmaceutical Services pays out 11.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Utah Medical Products has increased its dividend for 3 consecutive years. Utah Medical Products is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Utah Medical Products has a beta of 0.37, suggesting that its stock price is 63% less volatile than the broader market. Comparatively, West Pharmaceutical Services has a beta of 1.17, suggesting that its stock price is 17% more volatile than the broader market.

69.6% of Utah Medical Products shares are owned by institutional investors. Comparatively, 93.9% of West Pharmaceutical Services shares are owned by institutional investors. 8.0% of Utah Medical Products shares are owned by insiders. Comparatively, 0.6% of West Pharmaceutical Services shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

West Pharmaceutical Services has a consensus target price of $322.89, suggesting a potential upside of 7.58%. Given West Pharmaceutical Services' stronger consensus rating and higher possible upside, analysts clearly believe West Pharmaceutical Services is more favorable than Utah Medical Products.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Utah Medical Products	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
West Pharmaceutical Services	0 Sell rating(s)	4 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.75

In the previous week, West Pharmaceutical Services had 1 more articles in the media than Utah Medical Products. MarketBeat recorded 4 mentions for West Pharmaceutical Services and 3 mentions for Utah Medical Products. West Pharmaceutical Services' average media sentiment score of 0.43 beat Utah Medical Products' score of 0.42 indicating that West Pharmaceutical Services is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Utah Medical Products	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
West Pharmaceutical Services	0 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

West Pharmaceutical Services beats Utah Medical Products on 16 of the 20 factors compared between the two stocks.

Get Utah Medical Products News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding UTMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

UTMD vs. The Competition

Export

Metric	Utah Medical Products	MED PRODUCTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$203.94M	$8.18B	$6.34B	$12.37B
Dividend Yield	1.94%	2.53%	2.80%	5.35%
P/E Ratio	18.85	15.80	20.66	25.63
Price / Sales	5.26	8.38	547.76	76.59
Price / Cash	14.35	16.82	43.26	56.33
Price / Book	1.68	3.63	9.88	6.97
Net Income	$11.29M	$223.05M	$3.55B	$333.62M
7 Day Performance	-2.52%	-1.07%	1.69%	1.09%
1 Month Performance	-7.41%	1.86%	0.48%	3.08%
1 Year Performance	16.13%	2.20%	39.39%	35.68%

Utah Medical Products Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
UTMD Utah Medical Products	1.78 of 5 stars	$63.70 -0.5%	N/A	+17.2%	$203.94M	$38.52M	18.85	180	News Coverage
QDEL QuidelOrtho	3.68 of 5 stars	$11.12 +11.6%	$14.88 +33.8%	-66.1%	$679.18M	$2.66B	N/A	6,500
CERS Cerus	2.5676 of 5 stars	$2.55 +1.2%	$4.00 +56.9%	+100.8%	$504.93M	$206.13M	N/A	290	Positive News
OSUR OraSure Technologies	2.4364 of 5 stars	$2.97 -1.7%	$3.00 +1.0%	+18.5%	$207.92M	$115.02M	N/A	840
ANIK Anika Therapeutics	3.1253 of 5 stars	$14.68 +1.0%	$17.00 +15.8%	+35.5%	$193.46M	$112.82M	N/A	300	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:UTMD) was last updated on 5/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Utah Medical Products (UTMD) Competitors

UTMD vs. QDEL, CERS, OSUR, ANIK, and WST

How does Utah Medical Products compare to QuidelOrtho?

Summary

How does Utah Medical Products compare to Cerus?

Summary

How does Utah Medical Products compare to OraSure Technologies?

Summary

How does Utah Medical Products compare to Anika Therapeutics?

Summary

How does Utah Medical Products compare to West Pharmaceutical Services?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

UTMD vs. The Competition

Utah Medical Products Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Utah Medical Products (UTMD) Competitors

UTMD vs. QDEL, CERS, OSUR, ANIK, and WST

How does Utah Medical Products compare to QuidelOrtho?

Is UTMD or QDEL more profitable?

Do analysts recommend UTMD or QDEL?

Does the media favor UTMD or QDEL?

Which has more volatility & risk, UTMD or QDEL?

Do insiders and institutionals have more ownership in UTMD or QDEL?

Which has better earnings and valuation, UTMD or QDEL?

Summary

How does Utah Medical Products compare to Cerus?

Which has preferable earnings & valuation, CERS or UTMD?

Do insiders & institutionals have more ownership in CERS or UTMD?

Which has more risk and volatility, CERS or UTMD?

Is CERS or UTMD more profitable?

Does the media prefer CERS or UTMD?

Do analysts prefer CERS or UTMD?

Summary

How does Utah Medical Products compare to OraSure Technologies?

Is UTMD or OSUR more profitable?

Do institutionals & insiders have more ownership in UTMD or OSUR?

Which has more risk & volatility, UTMD or OSUR?

Which has higher earnings and valuation, UTMD or OSUR?

Do analysts prefer UTMD or OSUR?

Does the media prefer UTMD or OSUR?

Summary

How does Utah Medical Products compare to Anika Therapeutics?

Is UTMD or ANIK more profitable?

Do insiders and institutionals have more ownership in UTMD or ANIK?

Which has more volatility and risk, UTMD or ANIK?

Which has stronger earnings & valuation, UTMD or ANIK?

Do analysts rate UTMD or ANIK?

Does the media favor UTMD or ANIK?

Summary

How does Utah Medical Products compare to West Pharmaceutical Services?

Is UTMD or WST more profitable?

Which has stronger earnings and valuation, UTMD or WST?

Is UTMD or WST a better dividend stock?

Which has more risk and volatility, UTMD or WST?

Do insiders and institutionals have more ownership in UTMD or WST?

Do analysts rate UTMD or WST?

Does the media refer more to UTMD or WST?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

UTMD vs. The Competition

Utah Medical Products Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools